FDA approves generic version of Cymbalta: 3 things to know

The Food and Drug Administration on Monday approved Solco Healthcare’s duloxetine delayed-release capsules.

Advertisement

Here are three things to know.

  1. Duloxetine is used to treat major depressive disorder, general anxiety disorder and fibromyalgia.
  1. The drug represents a generic version of Eli Lilly’s Cymbalta.
  1. Both brand name and generic sales of duloxetine hit $484.4 million for the 12 months ending in June 2017, according to data from QuintilesIMS.

More articles on supply chain:

US Bioservices to pay $13.4M to resolve kickback suit
Patients brace for price of ‘breakthrough’ leukemia drug CTL019
Price of first FDA-approved ALS treatment in 20 years limits patient access at VCU Medical Center

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.